Global Precision Cancer Diagnostic Tests Market Forecasts 2019-2029

高精度がん診断テストの世界市場2019-2029

◆タイトル:Global Precision Cancer Diagnostic Tests Market Forecasts 2019-2029
◆商品コード:VGN910343
◆調査・発行会社:visiongain
◆発行日:2019年6月6日
◆ページ数:195
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle UserGBP3,499 ⇒換算¥500,357見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算¥557,557見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算¥714,857見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"高精度がん診断テストの世界市場2019-2029"について調査・分析し、レポートサマリー、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、主要企業分析、結論などの情報をお届けいたします。

The global precision cancer diagnostics tests market was estimated at $3.94 bn in 2018 and is expected to grow at a CAGR of 22.1% during the forecast period. The lung cancer submarket held 23% of the global precision cancer diagnostic tests market in 2018.How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 195-page report you will receive 131 tables and 66 figures– all unavailable elsewhere.
The 195-page report provides clear detailed insight into the global checkpoint inhibitors for anti-cancer treatment market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Precision Cancer Diagnostics Tests Market revenues forecast from 2019-2029
• Global Precision Cancer Diagnostics Tests Market revenues forecast from 2019-2029 by Cancer Type:
• Lung Cancer
• Breast Cancer: HER-2 Positive, HR Positive, TNBC
• Colorectal Cancer
• Other Cancers

• Global Precision Cancer Diagnostics Tests Market revenues forecast from 2019-2029 by Biopsy Type:
• Tissue Biopsy
• Liquid Biopsy
• Global Precision Cancer Diagnostics Tests Market revenues forecast from 2019-2029 by Regional and National market:
• US
• Japan
• Germany
• France
• Italy
• UK
• Spain
• China
• India
• Brazil
• Russia
The forecast of each country is further broken down by cancer type and biopsy type.
• Profile of the selected leading companies:
• Abbott Laboratories
• Agilent Technologies, Inc.
• bioMerieux SA
• Genomic Health, Inc.
• Illumina, Inc.
• Myriad Genetics, Inc.
• Qiagen N.V.
• Roche Holding AG
• Siemens Healthineers
• Thermo Fisher Scientific, Inc.
• Analysis of factors that drive and restrain the global precision cancer diagnostics tests market
• Key Questions Answered by this Report:
• How the global precision cancer diagnostic tests market is evolving?
• What are the drivers, restraints and opportunities in the global precision cancer diagnostic tests market?
• How will each of the sub-markets of the precision cancer diagnostic tests market develop over the period of study?
• Who are the leading players in the precision cancer diagnostic tests market and what are their future perspective during the period of study?
• What are the recent developments in the global precision cancer diagnostic tests market?
Visiongain’s study is intended for anyone requiring commercial analyses for the Global Precision Cancer Diagnostics Test Market. You find data, trends and predictions.
Buy our report today Precision Cancer Diagnostic Tests Market Forecasts 2019-2029: Lung Cancer, Breast Cancer, Colorectal Cancer, Blood Cancer, Gastric Cancer, HER-2 Positive, HR Positive, TNBC, Tissue Biopsy, Liquid Biopsy.

【レポートの目次】

1. Report Overview
1.1 Global Precision Cancer Diagnostic Tests Market Overview
1.2 Why You Should Read This Report
1.3 How the Report Delivers
1.4 Key Questions Answered by This Analytical Report Include
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports

2. Introduction to Precision Medicine
2.1 Evolution and Brief History of Precision Medicine
2.2 Key Benefits of Precision Medicine
2.3 Precision Medicine: Key Application Areas
2.4 Precision Medicine: Key Elements
2.5 Precision Medicine: Different Type of Data Used by Big Data Companies
2.6 Precision Medicine: Area of Interest

3. Qualitative Analysis
3.1 Market Dynamics
3.1.1 Drivers and Opportunities
3.1.1.1 Growing Volume of Precision Cancer Diagnostic Tests Receiving Regulatory Approval
3.1.1.2 Improving Reimbursement Scenario in the Developed Markets
3.1.1.3 Government Support for Precision Medicine
3.1.1.4 Precision Cancer Assays Based on Liquid Biopsies Offer High Growth Opportunities
3.1.1.5 Growing Aging Population and Cancer Prevalence
3.1.2 Restraints and Challenges
3.1.2.1 High Cost of Precision Tests and Therapies
3.1.2.2 Limited Access and Delay in Test Results
3.2 Regulatory Analysis: Precision Diagnostics (Companion Diagnostics)

4. Precision Cancer Diagnostic Tests Market by Cancer Type
4.1 Lung Cancer
4.2 Breast Cancer
4.2.1 HER2 Positive Breast Cancer
4.2.2 Hormone Receptor (HR)-positive Breast Cancer
4.2.3 Triple Negative Breast Cancer
4.3 Colorectal Cancer
4.4 Blood Cancer
4.5 Stomach (Gastric) Cancer
4.6 Other Cancers

5. Precision Cancer Diagnostic Tests Market by Biopsy Method
5.1 Tissue Biopsy
5.2 Liquid Biopsy

6. Leading National Precision Cancer Diagnostic Tests Markets, 2018-2029
6.1 US
6.2 Japan
6.3 Germany
6.4 France
6.6 Italy
6.6 UK
6.7 Spain
6.8 China
6.9 India
6.10 Brazil
6.11 Russia

7. Leading Companies in the Precision Cancer Diagnostic Tests Market
7.1 Roche Holding AG
7.1.1 Roche: Precision Cancer Diagnostics Product Portfolio
7.1.2 Sales and Recent Performance Analysis, 2017
7.1.3 Recent Developments
7.1.3.1 FDA Approval for triple-Negative Breast Cancer Test
7.1.3.2 Collaboration with Phoenix Molecular Designs (PhoenixMD)
7.1.3.3 Partnership with Merck to develop pan-cancer companion diagnostic test
7.1.3.4 Collaboration Agreement with Daiichi Sankyo
7.1.3.5 FDA Approval for cobas EGFR Mutation Test v2 as a companion diagnostic test (CDx) with IRESSA
7.1.3.6 Roche acquires Foundation Medicine
7.1.3.7 Collaboration with Five Prime Therapeutics
7.1.3.8 Extension of Collaboration Agreement with Pierre Fabre
7.1.3.9 FDA Approval for cobas EGFR Mutation Test v2 as a Companion Diagnostic with Tagrisso
7.1.3.10 FDA Approval for Ventana ALK (D5F3) companion diagnostic for Alecensa
7.1.3.11 CE Mark for the VENTANA anti-ALK (D5F3) Rabbit Monoclonal Primary Antibody
7.1.3.12 FDA Approval for VENTANA ALK (D5F3) CDx Assay
7.1.3.13 FDA Approval for cobas EGFR Mutation Test v2
7.2 Illumina, Inc.
7.2.1 Sales and Recent Performance Analysis, 2017
7.2.2 Illumina: Precision Cancer Diagnostics Product Portfolio
7.2.3 Recent Developments
7.2.3.1 Partnership with Loxo Oncology
7.2.3.2 FDA Approval for Praxis Extended RAS Panel
7.3 Thermo Fisher Scientific, Inc.
7.3.1 Sales and Recent Performance Analysis, 2017
7.3.2 Thermo Fisher: Precision Cancer Diagnostics Product Portfolio
7.3.3 Recent Developments
7.3.3.1 Agreement with Daiichi Sankyo and Takeda Pharmaceutical
7.3.3.2 Companion Diagnostic Partnership with Spectrum Pharmaceuticals, Inc.
7.3.3.3 Companion Diagnostic Development Agreement with Blueprint Medicines
7.3.3.4 Companion Diagnostic Partnership with Agios Pharmaceuticals, Inc.
7.4 Qiagen, N.V.
7.4.1 Sales and Recent Performance Analysis, 2018
7.4.2 Qiagen: Precision Cancer Diagnostics Product Portfolio
7.4.3 Recent Developments
7.4.3.1 Collaboration with Novartis
7.4.3.2 Launch of the QIAscreen HPV PCR Test
7.4.3.3 Launch of Innovative Sample to Insight workflows
7.4.3.4 FDA Approval to Expand Use of EGFR Test
7.4.3.5 Collaboration with Japan’s clinical laboratory testing company, SRL, Inc.
7.4.3.6 Public-private Alliance in the U.K.
7.4.3.7 Launch of AdnaTest Liquid Biopsy Kits in Prostate and Lung Cancer
7.4.3.8 Partnership with Natera
7.4.3.9 Launch of Predictive therascreen PITX2 Test in Europe
7.4.3.10 FDA Clearance for JAK2 Test
7.4.3.11 FDA Approval to Expand Use of EGFR test in Lung Cancer
7.4.3.12 Partnership with Clinical Genomics
7.4.3.13 Partnership with Bristol-Myers Squibb
7.4.3.14 Commercialisation of the Research Use Only AdnaTest Prostate Cancer Panel AR-V7
7.4.3.15 FDA Clearance of JAK2 Test for Leukemia
7.5 Abbott Laboratories
7.5.1 Abbott: Precision Cancer Diagnostics Product Portfolio
7.5.2 Sales and Recent Performance Analysis, 2017
7.5.3 Recent Developments
7.5.3.1 FDA Approvals
7.6 bioMérieux SA
7.6.1 bioMérieux: Precision Cancer Diagnostics Product Portfolio
7.6.3 Recent Developments
7.7 Agilent Technologies, Inc.
7.7.1 Agilent Technologies: Precision Cancer Diagnostics Product Portfolio
7.7.2 Sales and Recent Performance Analysis, 2018
7.7.3 Recent Developments
7.7.3.1 Expanded FDA Approval for Urothelial Carcinoma
7.7.3.2 Expanded FDA Approval for Cervical Cancer
7.7.3.3 Acquisition of Lasergen, Inc.
7.7.3.4 Expanded FDA Approval for Gastric or Gastroesophageal Junction (GEJ) Cancer
7.7.3.5 Expanded FDA Approval for PD-L1 IHC 28-8 pharmDx
7.7.3.6 Introduction of the AriaDx Real-Time PCR System
7.7.3.7 Agreement with Agendia, Inc.
7.8 Siemens Healthineers (A Division of Siemens AG)
7.8.1 Siemens: Precision Cancer Diagnostics Product Portfolio
7.8.2 Sales and Recent Performance Analysis, 2018
7.8.3 Recent Developments
7.9 Myriad Genetics, Inc.
7.9.1 Myriad Genetics: Precision Cancer Diagnostics Product Portfolio
7.9.2 Sales and Recent Performance Analysis, 2017
7.9.3 Recent Developments
7.9.3.1 Expansion of Companion Diagnostic Partnership
7.9.3.2 Approval of BRACAnalysis CDx for Advanced Ovarian Cancer Therapy- Lynparza
7.9.3.3 Approval of BRACAnalysis CDx for advanced ovarian cancer therapy- TALZENNA
7.9.3.4 Laboratory Agreement with Pfizer
7.9.3.5 Approval of BRACAnalysis CDx for Metastatic Breast Cancer Therapy- Lynparza
7.9.3.6 Expanded Research Collaboration with AstraZeneca
7.9.3.7 Companion Diagnostic Collaboration with Clovis Oncology
7.9.3.8 Companion Diagnostic Collaboration with BeiGene
7.10 Genomic Health, Inc.
7.10.1 Genomic Health: Precision Cancer Diagnostics Product Portfolio
7.10.2 Sales and Recent Performance Analysis, 2017
7.10.3 Recent Developments
7.10.3.1 Expansion of Collaboration with Biocartis
7.10.3.2 Launch of Oncotype DX AR-V7 Nucleus Detect
7.10.3.3 Research Collaboration with Janssen Pharmaceuticals
7.10.3.4 Strategic Collaboration with Cleveland Diagnostics
7.10.3.5 Agreement with Biocartis to Develop an Idylla IVD Oncotype DX Breast Cancer Test

8. Conclusions
8.1 The Precision Cancer Diagnostic Tests Market Will Exhibit Lucrative Growth through 2029
8.2 Lung Cancer is the Largest Submarket
8.3 Liquid Biopsy Based Diagnostic Tests Will Offer Significant Growth Opportunities
8.4 Prominent Companies in the Market
8.5 Leading Regional Markets
8.6 Concluding Remarks

Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain

List of Tables
Table 2.1 Key Benefits of Precision Medicine
Table 2.2 Key Elements of Precision Medicine
Table 4.1 Global Precision Cancer Diagnostic Tests Market by Cancer Type: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.2 Global Precision Cancer Diagnostic Tests Market by Cancer Type: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.3 Global Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue ($m), Market Share (%), 2018 vs. 2024 vs. 2029
Table 4.4 Global Precision Cancer Diagnostic Tests Market for Lung Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.5 Global Precision Cancer Diagnostic Tests Market for Lung Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.6 Global Precision Cancer Diagnostic Tests Market for Breast Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.7 Global Precision Cancer Diagnostic Tests Market for Breast Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.8 Global Precision Cancer Diagnostic Tests Market for Breast Cancer by Type: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.9 Global Precision Cancer Diagnostic Tests Market for Breast Cancer by Type: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.10 Global Precision Cancer Diagnostic Tests Market for Breast Cancer by Type: Revenue ($m), Market Share (%), 2018 vs. 2024 vs. 2029
Table 4.11 Global Precision Cancer Diagnostic Tests Market for HER2 Positive Breast Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.12 Global Precision Cancer Diagnostic Tests Market for HER2 Positive Breast Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.13 Global Precision Cancer Diagnostic Tests Market for HR Positive Breast Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.14 Global Precision Cancer Diagnostic Tests Market for HR Positive Breast Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.15 Global Precision Cancer Diagnostic Tests Market for TNBC: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.16 Global Precision Cancer Diagnostic Tests Market for TNBC: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.17 Global Precision Cancer Diagnostic Tests Market for Colorectal Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.18 Global Precision Cancer Diagnostic Tests Market for Colorectal Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.19 US Precision Cancer Diagnostic Tests Market for Blood Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.20 US Precision Cancer Diagnostic Tests Market for Blood Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.21 German Precision Cancer Diagnostic Tests Market for Blood Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.22 German Precision Cancer Diagnostic Tests Market for Blood Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.23 US Precision Cancer Diagnostic Tests Market for Gastric Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.24 US Precision Cancer Diagnostic Tests Market for Gastric Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.25 German Precision Cancer Diagnostic Tests Market for Gastric Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.26 German Precision Cancer Diagnostic Tests Market for Gastric Cancer: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 4.27 Global Precision Cancer Diagnostic Tests Market for Other Cancers: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 4.28 Global Precision Cancer Diagnostic Tests Market for Other Cancers: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 5.1 Global Precision Cancer Diagnostic Tests Market by Biopsy Type: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 5.2 Global Precision Cancer Diagnostic Tests Market by Biopsy Type: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 5.3 Global Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue ($m), Market Share (%), 2018 vs. 2024 vs. 2029
Table 5.4 Global Precision Cancer Diagnostic Tests Market for Tissue Biopsy: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 5.5 Global Precision Cancer Diagnostic Tests Market for Tissue Biopsy: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 5.6 Global Precision Cancer Diagnostic Tests Market for Liquid Biopsy: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2018-2024
Table 5.7 Global Precision Cancer Diagnostic Tests Market for Liquid Biopsy: Market Forecast Revenue ($m), Annual Growth (%) and CAGR (%), 2024-2029
Table 6.1 Precision Cancer Diagnostic Tests Market: Regional Sales ($m) and Market Shares (%), 2018, 2024 and 2029
Table 6.2 Precision Cancer Diagnostic Tests Market: National and Regional Revenue Forecasts ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.3 Precision Cancer Diagnostic Tests Market: National and Regional Revenue Forecasts ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.4 US Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.5 US Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.6 US Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.7 US Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.8 US Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.9 US Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.10 US Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.11 US Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.12 Japanese Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.13 Japanese Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.14 Japanese Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.15 Japanese Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.16 Japanese Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.17 Japanese Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.18 Japanese Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.19 Japanese Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.20 German Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.21 German Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.22 German Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.23 German Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.24 German Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.25 German Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.26 German Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.27 German Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.28 French Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.29 French Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.30 French Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.31 French Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.32 French Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.33 French Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.34 French Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.35 French Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.36 Italian Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.37 Italian Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.38 Italian Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.39 Italian Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.40 Italian Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.41 Italian Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.42 Italian Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.43 Italian Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.44 UK Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.45 UK Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.46 UK Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.47 UK Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.48 UK Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.49 UK Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.50 UK Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.51 UK Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.52 Spanish Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.53 Spanish Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.54 Spanish Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.55 Spanish Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.56 Spanish Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.57 Spanish Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.58 Spanish Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.59 Spanish Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.60 Chinese Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.61 Chinese Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.62 Chinese Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.63 Chinese Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.64 Chinese Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.65 Chinese Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.66 Chinese Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.67 Chinese Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.68 Indian Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.69 Indian Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.70 Indian Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.71 Indian Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.72 Indian Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.73 Indian Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.74 Indian Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.75 Indian Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.76 Brazilian Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.77 Brazilian Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.78 Brazilian Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.79 Brazilian Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.80 Brazilian Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.81 Brazilian Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.82 Brazilian Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.83 Brazilian Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.84 Russian Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.85 Russian Precision Cancer Diagnostic Tests Market: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.86 Russian Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.87 Russian Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.88 Russian Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.89 Russian Precision Breast Cancer Diagnostic Tests Market, By Subtype: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 6.90 Russian Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2018-2024
Table 6.91 Russian Precision Cancer Diagnostic Tests Market, by Biopsy Type: Revenue Forecast ($m), Annual Growth (%), and CAGR (%), 2024-2029
Table 8.1 Precision Cancer Diagnostic Tests Market: Submarket (Cancer Type) Forecasts ($m) and Market Shares (%), 2018, 2024 and 2029
Table 8.2 Precision Cancer Diagnostic Tests Market: Submarket (Biopsy type) Forecasts ($m) and Market Shares (%), 2018, 2024 and 2029
Table 8.3 Precision Cancer Diagnostic Tests National Market: Revenue Forecasts ($m) and Market Shares (%), 2018, 2024, and 2029

List of Figures
Figure 1.1 Global Precision Cancer Diagnostic Tests Market – Segmentation by Cancer Type
Figure 1.2 Global Precision Cancer Diagnostic Tests Market – Segmentation by Biopsy Method
Figure 1.3 Global Precision Cancer Diagnostic Tests Market – Segmentation by Geography
Figure 2.1 History of Precision Medicine
Figure 2.2 Key Areas of Application of Precision Medicine
Figure 2.3 Key Different Type of Data Used by Big Data Companies in Precision Medicine
Figure 2.4 Key Areas of Interest of Precision Medicine
Figure 4.1 Global Precision Cancer Diagnostic Tests Market for Lung Cancer: Market Forecast Revenue ($m), 2018-2029
Figure 4.2 Global Precision Cancer Diagnostic Tests Market for Breast Cancer: Market Forecast Revenue ($m), 2018-2029
Figure 4.3 Global Precision Cancer Diagnostic Tests Market for HER2 Positive Breast Cancer: Market Forecast Revenue ($m), 2018-2029
Figure 4.4 Global Precision Cancer Diagnostic Tests Market for HR Positive Breast Cancer: Market Forecast Revenue ($m), 2018-2029
Figure 4.5 Global Precision Cancer Diagnostic Tests Market for TNBC: Market Forecast Revenue ($m), 2018-2029
Figure 4.6 Global Precision Cancer Diagnostic Tests Market for Colorectal Cancer: Market Forecast Revenue ($m), 2018-2029
Figure 4.7 US Precision Cancer Diagnostic Tests Market for Blood Cancer: Market Forecast Revenue ($m), 2018-2029
Figure 4.8 German Precision Cancer Diagnostic Tests Market for Blood Cancer: Market Forecast Revenue ($m), 2018-2029
Figure 4.9 US Precision Cancer Diagnostic Tests Market for Gastric Cancer: Market Forecast Revenue ($m), 2018-2029
Figure 4.10 German Precision Cancer Diagnostic Tests Market for Gastric Cancer: Market Forecast Revenue ($m), 2018-2029
Figure 4.11 Global Precision Cancer Diagnostic Tests Market for Other Cancers: Market Forecast Revenue ($m), 2018-2029
Figure 5.1 Global Precision Cancer Diagnostic Tests Market for Tissue Biopsy: Market Forecast Revenue ($m), 2018-2029
Figure 5.2 Global Precision Cancer Diagnostic Tests Market for Liquid Biopsy: Market Forecast Revenue ($m), 2018-2029
Figure 6.1 Global Precision Cancer Diagnostic Tests National Market Share (%), 2018
Figure 6.2 Global Precision Cancer Diagnostic Tests National Market Share (%), 2029
Figure 6.3 US Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.4 US Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.5 US Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.6 US Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.7 Japanese Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.8 Japanese Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.9 Japanese Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.10 Japanese Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.11 German Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.12 German Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.13 German Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.14 German Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.15 French Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.16 French Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.17 French Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.18 French Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.19 Italian Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.20 Italian Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.21 Italian Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.22 Italian Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.23 UK Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.24 UK Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.25 UK Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.26 UK Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.27 Spanish Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.28 Spanish Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.29 Spanish Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.30 Spanish Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.31 Chinese Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.32 Chinese Precision Cancer Diagnostic Tests Market, by Cancer Type: Revenue, 2018-2029
Figure 6.33 Chinese Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.34 Chinese Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.35 Indian Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.36 Indian Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.37 Indian Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.38 Indian Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.39 Brazilian Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.40 Brazilian Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.41 Brazilian Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.42 Brazilian Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029
Figure 6.43 Russian Precision Cancer Diagnostic Tests Revenue ($m), 2018-2029
Figure 6.44 Russian Precision Cancer Diagnostic Tests Market by Cancer Type: Revenue, 2018-2029
Figure 6.45 Russian Precision Breast Cancer Diagnostic Tests Market by Subtype: Revenue, 2018-2029
Figure 6.46 Russian Precision Cancer Diagnostic Tests Market by Biopsy Type: Revenue, 2018-2029



★調査レポート[高精度がん診断テストの世界市場2019-2029] ( Global Precision Cancer Diagnostic Tests Market Forecasts 2019-2029 / VGN910343) 販売に関する免責事項
[高精度がん診断テストの世界市場2019-2029] ( Global Precision Cancer Diagnostic Tests Market Forecasts 2019-2029 / VGN910343) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆